Juli Schlichtiger
- Oncology top 10%
- Psychiatry and Mental health top 5%
- Pediatrics, Perinatology and Child Health top 10%
- Cellular and Molecular Neuroscience top 10%
- Molecular Biology
- Co-authors
- Anton PekcecHeidrun PotschkaAnika M. S. HartzEmma L. B. SoldnerJonna SoerensenJan A. GorterErwin A. van VlietBjörn Bauer
- Topics
- Epilepsy research and treatment (6 papers)Drug Transport and Resistance Mechanisms (6 papers)Pharmacological Effects and Toxicity Studies (4 papers)
- Journals
- Journal of NeuroscienceThe FASEB JournalJournal of Pharmacology and Experimental Therapeutics
- Partner nations
- GermanyUnited StatesNetherlands
In The Last Decade
Juli Schlichtiger
9 papers receiving 570 citations
Peers
Comparison fields: 5 of 72
- Oncology 234
- Psychiatry and Mental health 230
- Pediatrics, Perinatology and Child Health 174
- Cellular and Molecular Neuroscience 172
- Molecular Biology 138
Countries citing papers authored by Juli Schlichtiger
This map shows the geographic impact of Juli Schlichtiger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juli Schlichtiger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juli Schlichtiger more than expected).
Fields of papers citing papers by Juli Schlichtiger
This network shows the impact of papers produced by Juli Schlichtiger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juli Schlichtiger. The network helps show where Juli Schlichtiger may publish in the future.
Co-authorship network of co-authors of Juli Schlichtiger
This figure shows the co-authorship network connecting the top 25 collaborators of Juli Schlichtiger. A scholar is included among the top collaborators of Juli Schlichtiger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juli Schlichtiger. Juli Schlichtiger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 24 | |
| 2 | 121 | |
| 3 | 63 | |
| 4 | 1 | |
| 5 | 60 | |
| 6 | 37 | |
| 7 | 73 | |
| 8 | 116 | |
| 9 | 82 |
About Juli Schlichtiger
Juli Schlichtiger is a scholar working on Psychiatry and Mental health, Oncology and Pediatrics, Perinatology and Child Health, having authored 9 papers that have together received 577 indexed citations. Recurring topics across this work include Epilepsy research and treatment (6 papers), Drug Transport and Resistance Mechanisms (6 papers) and Pharmacological Effects and Toxicity Studies (4 papers). The work is most often cited by research in Psychiatry and Mental health (230 citations), Neurology (121 citations) and Cellular and Molecular Neuroscience (172 citations). Juli Schlichtiger has collaborated with scholars based in Germany, United States and Netherlands. Frequent co-authors include Anton Pekcec, Heidrun Potschka, Anika M. S. Hartz, Emma L. B. Soldner, Jonna Soerensen, Jan A. Gorter, Erwin A. van Vliet, Björn Bauer, Ralf G. Rempe and Richard J. Kryscio. Their work appears in journals such as Journal of Neuroscience, The FASEB Journal and Journal of Pharmacology and Experimental Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.